Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major -infected BALB/c mice

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis

(2017) A. Badirzadeh et al.   PARASITE IMMUNOLOGY

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

(2017) Alireza Badirzadeh et al.   PLoS Neglected Tropical Diseases

Detection of natural infection of Leishmania donovani (Kinetoplastida: Trypanosomatidae) in Phlebotomus argentipes (Diptera: Psychodidae) from a forest ecosystem in the Western Ghats, India, endemic for cutaneous leishmaniasis

(2016) R. Srinivasan et al.   ACTA TROPICA

Leishmania-based expression systems

(2016) Tahereh Taheri et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model

(2016) Maryam Heidari-Kharaji et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

(2016) Yasaman Taslimi et al.   Journal of Breast Cancer

Leishmaniasis and various immunotherapeutic approaches

(2016) Y. TASLIMI et al.   PARASITOLOGY

Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection

(2016) Mostafa Haji Molla Hoseini et al.   PARASITOLOGY INTERNATIONAL

Pediatric Cutaneous Leishmaniasis in an Endemic Region in Turkey: A Retrospective Analysis of 8786 Cases during 1998-2014

(2016) Mustafa Aksoy et al.   PLoS Neglected Tropical Diseases

Risk Mapping and Situational Analysis of Cutaneous Leishmaniasis in an Endemic Area of Central Iran: A GIS-Based Survey

(2016) Fatemeh Abedi-Astaneh et al.   PLoS One

Targeting Polyamine Metabolism for Finding New Drugs Against Leishmaniasis: A Review

(2015) Andrea Ilari et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model

(2015) A. Katebi et al.   MOLECULAR IMMUNOLOGY

Recent updates and perspectives on leishmaniasis

(2015) Dianella Savoia   Journal of Infection in Developing Countries

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

(2015) Mehdi Shahbazi et al.   PLoS One

IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine

(2014) Sudipta Bhowmick et al.   BMC MICROBIOLOGY

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen

(2014) Farnaz Zahedifard et al.   PLoS Neglected Tropical Diseases

Leishmaniasis in the Middle East: Incidence and Epidemiology

(2014) Nasir Salam et al.   PLoS Neglected Tropical Diseases

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis

(2014) Noushin Saljoughian et al.   Frontiers in Immunology

Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity

(2013) Elham Mohit et al.   MOLECULAR IMMUNOLOGY

Cutaneous and post kala-azar dermal leishmaniasis caused byLeishmania infantumin endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series

(2013) Alireza Badirzadeh et al.   Pathogens and Global Health

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

(2013) Noushin Saljoughian et al.   PLoS Neglected Tropical Diseases

Chemokine-based immunotherapy: delivery systems and combination therapies

(2012) Elham Mohit et al.   Immunotherapy

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections

(2012) Elham Mohit et al.   MOLECULAR IMMUNOLOGY

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

TLR4 and NKT Cell Synergy in Immunotherapy against Visceral Leishmaniasis

(2012) Subir Karmakar et al.   PLoS Pathogens

Recent advances in leishmaniasis treatment

(2011) Tatiana S. Tiuman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice

(2011) Gaurav Gupta et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Leishmaniasis: complexity at the host–pathogen interface

(2011) Paul Kaye et al.   NATURE REVIEWS MICROBIOLOGY

Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

(2010) Hiro Goto et al.   Expert Review of Anti-Infective Therapy

CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis

(2010) Shraddha A. Sane et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage

(2009) Miguel A. Morales et al.   EUKARYOTIC CELL

Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature

(2009) Ifeoma Okwor et al.   Immunotherapy

CXC Chemokine–Mediated Protection against Visceral Leishmaniasis: Involvement of the Proinflammatory Response

(2009) Gaurav Gupta et al.   JOURNAL OF INFECTIOUS DISEASES

Recombinant Protein Expression in Leishmania tarentolae

(2009) Giancarlo Basile et al.   MOLECULAR BIOTECHNOLOGY

Transgenic Leishmania and the immune response to infection

(2008) L. BEATTIE et al.   PARASITE IMMUNOLOGY